
Tian Zhang: Meet the Experts of VIRO 2025
The Global Voices in Renal Oncology (VIRO) Virtual Congress, organized by OncoDaily, will be held on September 11–12, 2025. Chaired by Dr. Rana R. McKay with co-chair Dr. Yüksel Ürün, this year’s program will feature around 50 leading experts in renal oncology from across the globe, sharing cutting-edge updates and future perspectives.
- The congress is free to attend.
- Register via the link.
Co-Chair of VIRO
Co-Chair of VIRO
Spotlight on Tian Zhang
Dr. Zhang is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center and serves as Associate Director of Clinical Research at the Simmons Comprehensive Cancer Center.
At the Global Voices in Renal Oncology (VIRO) Virtual Congress 2025, Dr. Zhang will present on “Current Standard of Care: IO/IO and IO/TKI Combinations.” Her presentation will cover:
- The development and clinical implementation of immune-oncology (IO) combinations in renal cell carcinoma.
- The comparative efficacy and safety of IO/IO versus IO/TKI treatment regimens.
- Biomarker-driven patient selection and personalized therapeutic strategies.
- Insights from ongoing clinical trials and future directions in immunotherapy for advanced RCC.
Dr. Zhang combines a strong clinical trial leadership role with translational research expertise, contributing to the advancement of personalized immunotherapy approaches in kidney cancer treatment.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023